Linzagolix with and without hormonal add-back therapy for symptomatic uterine fibroids: PRIMROSE 1 & 2 long-term extension and withdrawal study

Authors

Institutions

Publication Details

Journal
Fertility and Sterility
Published
2025-06-19
DOI
https://doi.org/10.1016/j.fertnstert.2025.06.016
Citations
2
Primary Topic
Uterine Myomas and Treatments
Type
article
Field-Weighted Citation Impact
4.11

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Linzagolix with and without hormonal add-back therapy for symptomatic uterine fibroids: PRIMROSE 1 & 2 long-term extension and withdrawal study

Jacques Donnez, Satoshi Hori, Elke Bestel, Felice Petraglia et al.
2 citations
Fertility and Sterility
Uterine Myomas and Treatments
4.11
article

Linzagolix with and without hormonal add-back therapy for symptomatic uterine fibroids: PRIMROSE 1 & 2 long-term extension and withdrawal study

Jacques Donnez, Satoshi Hori, Elke Bestel, Felice Petraglia, Christian Malte Becker, Marie‐Madeleine Dolmans, Hugh S. Taylor, Sven Becker, Francisco Carmona Herrera
article en
2 citations

Abstract

No abstract available for this paper.
Fertility and SterilityVol. 124(4)
Goethe University Frankfurt (DE), Cliniques Universitaires Saint-Luc (BE), OSRAM (United States) (US), Yale University (US), Endometriosis UK (GB), Hospital Clínic de Barcelona (ES), University of Florence (IT), UCLouvain (BE)
Kissei, Fonds De La Recherche Scientifique - FNRS
Openalex Percentile: Top 7%
Uterine Myomas and Treatments
4.11
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.